2013 American Transplant Congress
Continuous Coronary Sinus Perfusion for Recovery of Hearts from Non-Heart-Beating Donors
Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX
Purpose: DCD donors are not usually considered for heart transplantation. Recent studies suggest that machine perfusion appears promising for improving preservation of donor hearts and…2013 American Transplant Congress
Predicting Patient Survival after Kidney Transplantation (KTx): The First Year and Beyond
Nephrology and Transplantation, Mayo Clinic, Rochester, MN
Introduction: An important goal of pre-transplant evaluation is to identify candidates at risk for cardiovascular (CV) events and mortality post-transplant. Current approaches for risk assessment…2013 American Transplant Congress
With Induction, Donor Age, Recipient Age > 60, Female Gender, and Rejection Hinder Patient Survival after Liver Transplantation for HCV. Donor Age and Rejection Increase Severe Fibrosis, Whereas rATG May Be Protective
University of Washington, Seattle
As our center uses induction therapy in all OLTX recipients, we sought to examine the risk factors important for survival and fibrosis in OLTX for…2013 American Transplant Congress
High Levels of Plasma IL-21 Together with EBV-Specific Cytotoxic T Cells (EBVTc) May Contribute Avoidance to Post-Transplant (Tx) Lymphoroliferative Disorder (PTLD) in Pediatric Kidney Tx Patients (pts) Who Had Persistent EBV Infection (PEBV)
Background: PEBV infection is associated with high risk for development of PTLD. Recent studies report a critical role for IL-21 in sustaining viral-specific Tc activity…2013 American Transplant Congress
Rituximab or Alemtuzumab Induction for ABO Incompatible Renal Transplantation?
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom
ABO incompatible [ABOi] live-donor renal transplantation is a successful and accepted form of treatment for patients with end stage renal failure. Most antibody removal protocols…2013 American Transplant Congress
Safety and Efficacy of Peginterferon-α2a Plus Ribavirin Treatment in Renal Transplant Recipients with Chronic Hepatitis C; Prospective Cohort Study
Chronic hepatitis C virus (HCV) significantly impacts on the survival of renal transplant (RT) recipients. Interferon (IFN)-based therapy in RT recipients has been associated with…2013 American Transplant Congress
Collapsing Glomerulopathy of the Kidney Allograft: Is It Different from Idiopathic Collapsing Glomerulopathy of Native Kidney?
Collapsing Glomerulopathy (CG) is a histological entity characterized by glomerular capillary collapse, wrinkling and retraction of the glomerular basement membrane, and glomerular epithelial cell hypertrophy…2013 American Transplant Congress
Utilization of Compatible Pairs in a Large Kidney Paired Donation Program
Background: Our center has established a very large single center kidney paired donation (KPD) program. A significant barrier to KPD transplant has been the unbalanced…2013 American Transplant Congress
Priority Pass to Death – Prioritization of Liver Transplant for HCC Worsens Survival, A
Center for Liver Disease And Transplantation, Columbia University Medical Centre, New York, NY
Background – The current UNOS allocation system gives priority to patients with HCC to receive livers. This can potentially cause significant regional disparities in organ…2013 American Transplant Congress
Hyperuricemia Is Associated with Both Histological Alteration in Implant Biopsy and Risk Factor of Donor’s Renal Function Decline after 1-Year in Living-Kidney Transplantation
Objective: Only living donation enables for timely kidney transplantation for patients with end stage renal disease. Donors's follow-up is often neglected, bringing up economic and…
- « Previous Page
- 1
- …
- 168
- 169
- 170
- 171
- 172
- …
- 178
- Next Page »